According to Bank of America, Lorillard LO coverage is transferred at Neutral.
Bank of America said that while it expects LO's operating results to continue to outpace its domestic peers, given 2011 performance (+39% for LO vs. a flat S&P) and near term uncertainty surrounding a pending FDA update on the independent peer review on menthol, it is transferring coverage at Neutral with a $121 target. “However, shares also carry the highest level of potentially binary risk, with menthol accounting for 85/90% of volume/profits, respectively.”
Lorillard closed yesterday at $113.86.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in